pulmonary vascular disease
Showing 1 - 25 of >10,000
Pulmonary Hypertension in Left Heart Disease
Not yet recruiting
- Pulmonary Hypertension
- +2 more
- Transthoracic Echocardiography (TTE)
- Lung ultrasound
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 29, 2023
Pulmonary Vascular Disease in CF
Recruiting
- Cystic Fibrosis
-
Indianapolis, Indiana
- +1 more
Nov 10, 2022
Pulmonary Vascular Disease, Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Active, not recruiting
- Pulmonary Vascular Disease
- +2 more
- Relocation from HA to LA
-
Zurich, SwitzerlandRespiratory Clinic, University Hospital of Zurich
Oct 17, 2023
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Active, not recruiting
- Pulmonary Vascular Disease
- +2 more
- Assessment without intervention at High altitude
- Relocation to sea level for 2 days
-
Zurich, SwitzerlandUniversity Hospital Zurich
Oct 2, 2023
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich
Recruiting
- Pulmonary Vascular Disease
- +2 more
- Relocation to sea level
-
Zurich, SwitzerlandUniversity Hospital Zurich
Aug 9, 2023
Pulmonary Vascular Disorder, Primary Pulmonary Hypertension, Systemic Sclerosis Trial in Dresden, Heidelberg (Riociguat Oral
Recruiting
- Pulmonary Vascular Disorder
- +3 more
- Riociguat Oral Tablet
- Placebo
-
Dresden, Germany
- +1 more
Jan 26, 2023
Pulmonary Vascular Disease Phenomics Program PVDOMICS
Active, not recruiting
- Pulmonary Arterial Hypertension
- No Intervention
-
Tucson, Arizona
- +6 more
Jan 27, 2023
Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zürich
Recruiting
- Pulmonary Vascular Disease
- +2 more
- 6-minute walk distance (6MWD) test
- 6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)
-
Zürich, SwitzerlandUniversity Hospital Zürich
Aug 18, 2023
Scleroderma, Mildly Elevated Pulmonary Pressures Trial in New Orleans, Baltimore (Sildenafil, Placebo)
Recruiting
- Scleroderma
- Mildly Elevated Pulmonary Pressures
- Sildenafil
- Placebo
-
New Orleans, Louisiana
- +1 more
Sep 8, 2022
PIMR and Pulmonary Vascular Disease
Recruiting
- Pulmonary Hypertension
- Pulmonary Index of Microcirculatory Resistance
- +2 more
-
Los Angeles, CaliforniaRonald Reagan UCLA Medical Center
Apr 24, 2023
Chronic Thromboembolic Pulmonary Hypertension Trial in Beijing (Balloon pulmonary angioplasty)
Recruiting
- Chronic Thromboembolic Pulmonary Hypertension
- Balloon pulmonary angioplasty
-
Beijing, China
- +1 more
Dec 27, 2022
Pulmonary Vascular Disease Trial in Durham (GE-141, Hyperpolarized 129Xenon gas, MRI)
Completed
- Pulmonary Vascular Disease
- GE-141, Hyperpolarized 129Xenon gas
- MRI
-
Durham, North CarolinaDuke University Medical Center
Jan 28, 2022
Pulmonary Hypertension, Medication Therapy Management Trial in Beijing
Not yet recruiting
- Pulmonary Hypertension
- Medication Therapy Management
-
Beijing, Chinacenter of pulmonary vascular disease, Fuwai hospital
Sep 21, 2022
Pulmonary Arterial Hypertension Trial in China (The clinical course and disease management)
Recruiting
- Pulmonary Arterial Hypertension
- The clinical course and disease management
-
Guangzhou, Guangdong, China
- +12 more
May 10, 2022
Pulmonary Arterial Hypertension, Randomized Controlled Trial Trial in Beijing (Tolvaptan, Furosemide)
Recruiting
- Pulmonary Arterial Hypertension
- Randomized Controlled Trial
-
Beijing, Chinacenter of pulmonary vascular disease, Fuwai hospital
Oct 4, 2022
Pulmonary Vascular Disease Trial in Durham (Hyperpolarized 129Xenon gas)
Recruiting
- Pulmonary Vascular Disease
- Hyperpolarized 129Xenon gas
-
Durham, North CarolinaDuke University Medical Center
Oct 3, 2022
Heart Failure Trial in Tbilisi (ALV1System)
Recruiting
- Heart Failure
- ALV1System
-
Tbilisi, GeorgiaTbilisi Heart and Vascular
Aug 12, 2022
Pulmonary Vascular Disease, Pulmonary Arterial Hypertension Trial in Canada, United States
Recruiting
- Pulmonary Vascular Disease
- Pulmonary Arterial Hypertension
-
Palo Alto, California
- +7 more
Aug 10, 2022
Repeatability of NT-proBNP Testing Using Laboratory and Point of
Active, not recruiting
- Pulmonary Artery Hypertension
- Exercise group
-
Sheffield, South Yorkshire, United KingdomPulmonary Vascular Disease Unit, Royal Hallamshire Hospital
Jun 14, 2022
Pulmonary Vascular Dysfunction asCause of Persistent Exertional
Recruiting
- COVID-19
- pulmonary vascular dysfunction
- pulmonary vascular function
-
Giessen, GermanyNatascha Sommer
May 13, 2022
Ventricular and Pulmonary Vascular Reserve After Fontan
Recruiting
- Heart Failure
- Congenital Heart Disease
- rest-exercise echocardiography
-
Rochester, MinnesotaMayo Clinic
Mar 1, 2022
Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension Trial in Shenyang (Pulmonary arterial
Not yet recruiting
- Pulmonary Hypertension
- +7 more
- Pulmonary arterial denervation
- Guideline-directed medical therapy (GDMT) for heart failure
-
Shenyang, Liaoning, ChinaGeneral Hospital of Northern Theater Command
Apr 10, 2023
Diabetic Foot, Diabetes, Peripheral Arterial Disease Trial in Düsseldorf (percutaneous transluminal angioplasty)
Not yet recruiting
- Diabetic Foot
- +8 more
- percutaneous transluminal angioplasty
-
Düsseldorf, GermanyUniversity-Hospital Düsseldorf Division of Cardiology, Pulmonary
Nov 8, 2023
Genomics in Heart Transplants
Not yet recruiting
- Heart Transplantation
-
Düsseldorf, GermanyUniversity-Hospital Düsseldorf Division of Cardiology, Pulmonary
Aug 21, 2023